Strategic Advisory Partner – Biotech & Pharma Portfolio Risk Intelligence
Panorad AI is the decision‑intelligence platform that simulates clinical, regulatory, and market outcomes across the biotech lifecycle.
Our Outcome Simulator models phase‑specific probabilities, tail risk, program dependencies, and commercial upside — before capital is deployed.
Secure, in‑tenant platform connects internal data, trial results, KOL insights, and real‑world signals to :
- Identify hidden failure risks early
- Priorize programs with the highest probability‑weighted value
- Accelerate diligence and eliminate surprises post‑invest
Fund managers already look to us to deliver fast, explainable conviction on complex scientific bets.
The Opportunity
We are adding one biotech‑specialized Strategic Advisory Partner to drive adoption among :
Biotech funds and crossover investorsPharma corporate development teamsHedge fund biotech PMsLife sciences risk and diligence consultantsYou’ll bring the network.
We’ll bring the technology that makes them faster and smarter.
This is fractional .
High‑leverage.
Outcome‑linked upside.
Why This Vertical Matters
Biotech is uncertainty.
Clinical riskRegulatory riskPipeline timing riskCapital runway riskCompetition and market access surprisesA single blind spot can wipe a fund year.Panorad AI makes that visible before decisions are locked :
Phase transition forecastingMechanism‑of‑action risk mappingCompetitive pipeline stress testsRegulatory pathway scenario simulationProbability‑weighted valuation deltasGive decision‑makers confidence backed by evidence .
What You Will Do
Generate warm intros to biotech decision‑makers (funds, BD&L leaders, PMs)Guide a 30‑day simulation pilot on active or recent programs / portfolioPressure‑test positioning and outcome metrics for scientific audiencesSupport creation of case studies proving predictive insight and ROIYou help secure one high‑conviction design partner.
We handle delivery and execution.
Ideal Partner Profile
You Are :
A seasoned biotech investor, PM, Corp Dev leader, or consulting partnerTrusted by those deploying capital into clinical scienceFluent in the language of MOA, endpoints, indication fit, trial design, market accessWired to move quickly when a better way presents itselfYour Network Includes :
Biotech funds managing $50M–$2B AUMPharma BD&L and external innovation decision‑makersRisk & diligence consultants inside leading life‑science advisoriesStrategic Upside
For You
Equity tied to measurable impactAccess to a tool that enhances your own deal decisionsBe early in defining how biotech capital allocators evaluate riskFor Panorad
Category leadership in the most risk‑sensitive investment marketIndustry validation by those who shape biotech decision frameworksAccelerated channel expansion into clinical‑stage capitalWhat Success Looks Like in 60 Days
10+ qualified biotech investor intros1–2 pilots analyzing live or historical programsMeasurable lift in decision speed and predictive accuracyFirst case study with LP‑quality evidenceLocation : Bay Area preferred (Remote OK)
Engagement : Fractional | Outcome‑based Upside
Timing : Immediate for the right partner
Use Panorad AI to See The Risk Before Investing In Biotech.
Seniority level
Mid‑Senior levelEmployment type
ContractJob function
Business Development and SalesSoftware Development#J-18808-Ljbffr